Investing.com - NuCana reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
NuCana announced earnings per share of £-0.001 on revenue of £0.00. Analysts polled by Investing.com anticipated EPS of £-0.001 on revenue of £0.00.
NuCana shares are down 55.46% from the beginning of the year and are trading at £1.060 , down-from-52-week-high.
NuCana follows other major Healthcare sector earnings this month
NuCana's report follows an earnings beat by Eli Lilly on Tuesday, November 1, 2022, who reported EPS of £1.98 on revenue of £6.94B, compared to forecasts EPS of £1.91 on revenue of £6.91B.
Pfizer had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of £1.78 on revenue of £22.6B, compared to forecast for EPS of £1.44 on revenue of £21.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar